ABSI Stock: Price, Earnings History and SEC Filings
Absci Corporation (ABSI) last traded at $11.13, down 8.02% on the latest session and up 3.3% over the past month. In its most recent reported quarter (Mar 2026) earnings per share were $-0.19 against an analyst estimate of $-0.20, a beat of 5.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ABSI earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Mar 2026 | May 7, 2026 | $-0.19 | $-0.20 | +5.00% |
| Dec 2025 | Mar 24, 2026 | $-0.23 | $-0.16 | -43.75% |
| Sep 2025 | Nov 12, 2025 | $-0.20 | $-0.19 | -5.26% |
ABSI beat the analyst EPS estimate in 1 of its last 3 reported quarters. Source: Nasdaq.
How ABSI reacts to earnings
Across its last 8 earnings releases, ABSI moved 6.7% on average the next session, in either direction. It rose after 3 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-11 | After close | +0.96% |
| 2026-05-07 | After close | +2.61% |
| 2026-03-24 | After close | -2.99% |
| 2025-11-12 | After close | -22.35% |
| 2025-08-12 | After close | +5.05% |
| 2025-05-13 | After close | -1.69% |
| 2025-03-18 | After close | -3.25% |
| 2024-11-12 | Before open | -14.95% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
ABSI financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $3M | -$115M | -$94M | -4113.7% | $-0.84 |
| 2024 | $5M | -$103M | -$73M | -2274.1% | $-0.94 |
| 2023 | $6M | -$111M | -$65M | -1933.6% | $-1.20 |
| 2022 | $5M | -$105M | -$98M | -2316.3% | $-1.15 |
| 2021 | $4M | -$101M | -$99M | -2518.3% | $-2.08 |
| 2020 | $4M | -$14M | -$13M | -348.6% | $-3.19 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for ABSI
- 10-Q · Aug 11, 2026
- 8-K · Aug 11, 2026Results of operations, Other events, Financial statements and exhibits
- 8-K · Jun 24, 2026Material agreement, Other events, Financial statements and exhibits
- 424B5 · Jun 24, 2026
- 8-K · Jun 24, 2026Other events
- 8-K · Jun 5, 2026Shareholder vote
- 10-Q · May 7, 2026
- 8-K · May 7, 2026Results of operations, Other events, Financial statements and exhibits
- DEF 14A · Apr 22, 2026
- 10-K · Mar 24, 2026
Insider filing activity
ABSI insiders filed 6 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ABSI news
- Absci Sinks 8%, Schrödinger and Recursion Slide as AI Drug Discovery Stocks Give Back RallyOct 30, 2026 · tikr.com
- Does Positive Hair Loss Trial Data Change The Bull Case For Absci Stock?Oct 30, 2026 · finance.yahoo.com
- Absci Soars 12%, Schrödinger Up 11%, Recursion Up 9% as AI Drug Discovery Stocks RallyOct 28, 2026 · tikr.com
- Absci to Participate in Upcoming Investor ConferencesOct 27, 2026 · finance.yahoo.com
- Is Absci (ABSI) Undervalued As Positive ABS 201 Phase 1 Data Lifts Optimism?Oct 24, 2026 · finance.yahoo.com
About Absci Corporation
Absci Corporation (ABSI) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-commercial Physical & Biological Research. Its fiscal year ends in December.